ALK and non-small cell lung carcinoma: Therefore, a comprehensive genomic testing of many known driver mutations in NSCLC specimens, including at least ALK, ROS1, RET, MET, ERBB2, BRAF and KRAS genes, has been proposed if NGS based methodology is performed [68].